- Home
- / Deepverge
Deepverge
Stock Price
€0
2023-12-27
Market Capitalization
€1.3 M
2023-12-27
Revenue
£9.3 M
FY, 2021
Deepverge Summary
Company Summary
- Overview
- Deepverge (formerly Integumen) is a technology company that manufactures and seller of pharmaceutical products. It offers artificial intelligence, clinical research, water technologies, medical devices, and other products.
- Type
- Public
- Status
- Active
- Founded
- 2016
- Website
- https://www.deepverge.com
- Cybersecurity rating
Table of Contents
Deepverge Financials
Summary Financials
- Revenue (H1, 2022)
- £6.4M
- Gross profit (H1, 2022)
- £3.6M
- Net income (H1, 2022)
- (£2.2M)
- Cash (H1, 2022)
- £1.2M
- EBIT (H1, 2022)
- (£2.1M)
- Enterprise value
- $6.4M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026